http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005531754-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-68 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-78 |
| filingDate | 2003-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2005-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2005531754-A |
| titleOfInvention | Detection of autoantibodies against cytokeratin 18 protein in patients with bronchial asthma and chronic rhinitis and uses including bronchial asthma and chronic rhinitis diagnostic kits containing mammalian cytokeratin 18 protein |
| abstract | The present invention is based on the surprising discovery of the presence of autoantibodies against cytokeratin 18 protein in serum samples of patients with bronchial asthma and chronic rhinitis, especially non-allergic patients. The present invention includes diagnostic methods and diagnostic kits for detecting bronchial asthma and chronic rhinitis patients associated with autoantibodies to cytokeratin 18. The present invention also includes methods and kits for prescribing and observing treatment for patients with bronchial asthma and chronic rhinitis by detecting autoantibodies to cytokeratin 18. Furthermore, the present invention relates to a pharmaceutical formulation comprising cytokeratin 18 protein for protecting patients with bronchial asthma and chronic rhinitis associated with autoantibodies to cytokeratin 18. In addition, the present invention treats patients with bronchial asthma and chronic rhinitis associated with autoantibodies against cytokeratin 18 protein by using such compounds that suppress the interaction between autoantibodies and cytokeratin 18 protein. It is also about the method for |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023153496-A1 |
| priorityDate | 2002-05-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 104.